ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000265.1|Rhodomycin_1 # 1 # 432 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.627	BGC0000265.1|Rhodomycin_1 	1	432	+	Loose	700	23.483	tet(47)	21.25	3004613	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	GATCGAATCGACATTGTTCGCCGCATGGTGAACAGCTACAACACCGGAAAAACGGATGACGTGGCCGAGTTCATCCACGAGGAGTACCTCAATCCCGGTGCCCTGGAACACATGCCGGAACTGCGCGGTCCCGAGGCGTTCGCACTCGCGGTGAAGTGGCTGAAGCTCACTTTCTCCGAGGACGCGCATCTGGAGGAGATCTCCTACGAGGAGAAAGGCAGCTGGGTGCGGGCGAAACTCGCCCTGTACGGACGTCAGGTGGGTGAACTCGTAGGAATGCCCGCCACCGGGCGCAAGTTCTCCGGCGAACAGATTCACCTCATCCGGATCGTCGACGGAAAGATCCGCGACCACCGCGACTGGCCCGACTATCTCGGCACCTACCGCCAGCTCGGCGAGCCGTGGCCCACCGAGGAGGGCTGGCGCCCCTGA	DRIDIVRRMVNSYNTGKTDDVAEFIHEEYLNPGALEHMPELRGPEAFALAVKWLKLTFSEDAHLEEISYEEKGSWVRAKLALYGRQVGELVGMPATGRKFSGEQIHLIRIVDGKIRDHRDWPDYLGTYRQLGEPWPTEEGWRP	MRCHFRCNLALPLLVFLNLSRAIKDYQTMSSINNILVIGAGIAGPSVCYWLKRFGFSPVLIEKSANLRKGGHALDVRGVAIDLVKRMGIYEKIGNRRTQVEFGRYMDTQGNILHEEKGERFCYREGEDVEITRGDLVEILIDAIEGVPCYLNQSIDSIKQRDGDVAVRFKDGKIEYYDLIIGADGLHSTTRRMVFDKDEYQLTNLGAYFSVFSIPNYLNLNHTEIQFEANQKLISMTSDKNPKMAEVAFMFRVQNVLNNRRDENEQKRFLRDTFQGFGWETSKILELMSDSDDFYFDSVSQVKMKSWTKGRVALLGDAGYCASPISGQGNNLALVGAYVLAGELKQASDNYHQAFNRYNELLHPFIEANQKLGVLVNESFLVQDEVSKEVAEERSNKIMEEVKIVSNMISLPDYE	34.46	gnl|BL_ORD_ID|4799|hsp_num:0	3308			870	1095	tetracycline; oxytetracycline
BGC0000265.1|Rhodomycin_2 # 474 # 1598 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.732	BGC0000265.1|Rhodomycin_2 	474	1598	+	Loose	500	29.261	chrB	29.81	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	GTGAGCTCTTCCTCACCCGGGGAACCCCTGGAACCGACCGACCAGGACCTCGACGTACTCCTGAAGAACCTCGGCAATCTGGTGACCCCGATGGCCCTGAGGGTCGCCGCGACACTCCGCCTGGTCGATCACCTGCTGGCCGGAGCCGACACCCTCGCCGGCCTCGCCGACCGTACGGACACCCATCCCCAGGCGCTCTCCCGCCTGGTCCGGCACCTGACCGTCGTCGGCGTCCTGGAGGGCGGCGAGAAGCAGGGCCGGCCGCTGCGCCCCACCCGGCTCGGGATGCTCCTCGCCGACGGCCACCCGGCCCAGCAGCGGGCCTGGCTGGACCTGAACGGGGCCGTCTCCCACGCCGACCTGGCCTTCACCGGGCTCCTCGACGTGGTCCGCACCGGCCGCCCCGCCTACGCCGGGCGGTACGGGCGGCCCTTCTGGGAGGACCTCTCGGCGGACGTGGCGCTGGCCGACTCCTTCGACGCGCTCATGTCCTGCGACGAGGACCTGGCCTACGAGGCCCCGGCCGACGCGTACGACTGGTCGGCGGTCCGGCACGTCCTCGACGTGGGCGGCGGCAACGGCGGCATGCTCGCGGCGATCGCCCTGCGGGCCCCGCACCTGCGCGGCACCCTGGTCGAACTGGCCGGTCCCGCCGAGCGCGCCCGGCGCAGGTTCGCGGACGCCGGTCTGGCCGACCGGGTCACGGTGGCGGAGGGCGACTTCTTCAAGCCGCTGCCCGTCACCGCCGACGTCGTCCTGCTGTCGTTCGTCCTGCTCAACTGGTCCGACGAGGACGCGCTGACGATCCTGCGCGGCTGCGTCAGGGCGCTGGAGCCGGGAGGCAGGCTCCTGGTCCTCGACCGTGCCGATGTCGAGGGGGACGGCGCCGACCGGTTCTTCAGCACGCTGCTCGACCTGCGGATGCTGACGTTCATGGGCGGACGGGTGCGCACCCGGGACGAGGTCGTGGACCTGGCCGGATCGGCCGGACTCGCCCTGGCCTCGGAGCGCACGAGCGGCTCCACGACCCTCCCGTTCGACTTCTCGATCCTCGAGTTCACGGCCGTCTCCGAGGAAGCGGCCCCGGCCGCCCAGGCCTCCGAAGCCCTCCCAGCACAGGAGTAG	MSSSSPGEPLEPTDQDLDVLLKNLGNLVTPMALRVAATLRLVDHLLAGADTLAGLADRTDTHPQALSRLVRHLTVVGVLEGGEKQGRPLRPTRLGMLLADGHPAQQRAWLDLNGAVSHADLAFTGLLDVVRTGRPAYAGRYGRPFWEDLSADVALADSFDALMSCDEDLAYEAPADAYDWSAVRHVLDVGGGNGGMLAAIALRAPHLRGTLVELAGPAERARRRFADAGLADRVTVAEGDFFKPLPVTADVVLLSFVLLNWSDEDALTILRGCVRALEPGGRLLVLDRADVEGDGADRFFSTLLDLRMLTFMGGRVRTRDEVVDLAGSAGLALASERTSGSTTLPFDFSILEFTAVSEEAAPAAQASEALPAQE	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	133.57	gnl|BL_ORD_ID|274|hsp_num:0	305			276	546	tylosin; chalcomycin; mycinamicin
BGC0000265.1|Rhodomycin_3 # 1603 # 2499 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.740	BGC0000265.1|Rhodomycin_3 	1603	2499	+	Loose	600	129.028	EstT	28.78	3007459	protein homolog model	n/a	n/a	macrolide antibiotic; glycylcycline; tetracycline antibiotic	antibiotic inactivation	macrolide esterase	ATGTCCGAACGCATCGTGCCGAGCGGGGACGTCGAGCTGTGGAGCGACGACTTCGGTGACCCGGCGGACCCGGCGCTGCTGCTCGTCATGGGCGGCAACCTCTCCGCCCTCGGCTGGCCCGACGAGTTCGCCCGGCGGCTCGCCGACGGCGGCCTCCACGTCATCCGCTACGACCACCGCGACACCGGCCGCTCCACCACCCGCGACTTCGCCGCGCACCCCTACGGCTTCGGCGAGCTGGCCGCCGACGCGGTCGCCGTCCTCGACGGCTGGGGCGTCGACCGGGCCCATGTCGTCGGCCTCTCGATGGGGGCGACCATCACCCAGGTCATCGCCCTCGACCACCACGACCGGCTGAGCAGCCTGACCATGCTGCTCGGCGGCGGGCTCGACATCGACTTCGACGCCAACATCGAGCGCGTGATGCGCGGCGAACCCACGCTGGACGGCCTGCCCGGGCCCCAGCAGCCGTTCCTGGACGCGCTCGCCCTGATGAACCAGCCGGCCGAGGGACGCGCCGCCGAGGTGGCCAAGCGCGTGAGCAAGTGGCGCATCCTCTCCGGCACGGGTGTGCCGTTCGACGACGCCGAGTACGCGCGGTGGGAGGAACGGGCGATCGACCACGCGGGGGGCGTCCTCGCCGAGCCGTACGCGCACTACTCGCTGACCCTGCCGCCGCCGTCCCGGGCCGCCGAGCTGCGCGAGGTCACCGTGCCGACCCTGGTCATCCAGGCCGAGCACGACCCCATCGCCCCCGCGCCGCACGGCAAGCACCTCGCCGGGCTCATCCCCACCGCGCGCCTCGCGGAGATCCCGGGCATGGGGCACGCCCTGCCTTCCTCGGTCCACGGGCCGCTCGCCGAGGTCATCCTCGCCCACACCCGCTCGGCGGCCTGA	MSERIVPSGDVELWSDDFGDPADPALLLVMGGNLSALGWPDEFARRLADGGLHVIRYDHRDTGRSTTRDFAAHPYGFGELAADAVAVLDGWGVDRAHVVGLSMGATITQVIALDHHDRLSSLTMLLGGGLDIDFDANIERVMRGEPTLDGLPGPQQPFLDALALMNQPAEGRAAEVAKRVSKWRILSGTGVPFDDAEYARWEERAIDHAGGVLAEPYAHYSLTLPPPSRAAELREVTVPTLVIQAEHDPIAPAPHGKHLAGLIPTARLAEIPGMGHALPSSVHGPLAEVILAHTRSAA	MKKKLLWILILGLIIISCKQRKTEMKEKIIKTNGIELCTESFGNKKNPAILLVAGATVSMLYWDTEFCQQLSEKGFFVIRYDNRDVGKSTNYEPGSTPYDIVDLTNDAISILDGYKIDKAHFVGISLGGLISQIASIKFADRVNSLTLMSSGPWGDSDPTIPEMDTSILDFHSKAGTVNWTNEDSVVNYLIQGAELMSGKKQFDKQRSEKLIRAEFNRANNYISMFNHAASQGGGGEEYWNRLNEIKQPTLIIHGTDDKIWHYKNAGFLLEKIKGSNLITLEGTGHELHVDDWKSIIDGIEKHIND	97.39	gnl|BL_ORD_ID|4956|hsp_num:0	5948			72	864	tigecycline
BGC0000265.1|Rhodomycin_4 # 2532 # 3245 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.724	BGC0000265.1|Rhodomycin_4 	2532	3245	+	Loose	400	33.113	Erm(30)	28.72	3001265	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGTACGGGGCCGACCTCGCCCGGGTCTACGACCTGGTGCACCGGGAGCGGGGCAAGGACTACCGGGCCCGAGACCGAGGCGGTCGCCGCCGCGGCCCGGCGGAGCAGGCCGGCGCCGGACGGCTGCTCGACGTCGCGTGCGGCACCGGAGGCCATCTGCGGCACTTCGCCGACCTCTTCGCCCACGTCGAGGGAGTGGAGCTGTCGGAGCCGATGGCCGAGGAGGCACGGGCCGCGCTGCCCGGGGTGACCGTGCACGCGGGCGACATGCGCGACTTCCGCCTCGGCACCACCTTCGACGTCGTGACCTGCATGTTCGGCTCCGTCGGCTATATGACGTCGGTCGCCGAACTCGGCCGGGCGCTGAGGATGTTCGCCCGGCATCTGGAGCCGGGCGGGGTGGCCGTGGTCGACCCGTGGTGGTTCTACGAGACGTTCGCCGACGGCCATGTCTCCGCCGACATCGTGACCGTCGACGGCGTCACCGTCTCCCGGGTCTCGCACTCCGCCCGCCGGGGCCGTACCTCGCACATGGACGTGCACTTCGTGGTCGCCGAACCCGGCGCCGGCGCCCAGCACTTCGTCGACACCCACATCATCTCCCTGTTCAGCCGCTCCGAGTACGAACAGGCCTTCCGCGACGCCGGCTTCGCGGTCGAGTACCTGCCCGAGGCGCCGTCGGGCCGCGGCCTGTTCGTCGGCGTCCGGGGGTGA	MYGADLARVYDLVHRERGKDYRARDRGGRRRGPAEQAGAGRLLDVACGTGGHLRHFADLFAHVEGVELSEPMAEEARAALPGVTVHAGDMRDFRLGTTFDVVTCMFGSVGYMTSVAELGRALRMFARHLEPGGVAVVDPWWFYETFADGHVSADIVTVDGVTVSRVSHSARRGRTSHMDVHFVVAEPGAGAQHFVDTHIISLFSRSEYEQAFRDAGFAVEYLPEAPSGRGLFVGVRG	MAMRDSIPRRADRDTLRRELGQNFLQDDRAVRNLVTHVEGDGRNVLEIGPGKGAITEELVRSFDTVTVVEMDPHWAAHVRRKFEGERVTVFQGDFLDFRIPRDIDTVVGNVPFGITTQILRSLLESTNWQSAALIVQWEVARKRAGRSGGSLLTTSWAPWYEFAVHDRVRASSFRPMPRVDGGVLTIRRRPQPLLPESASRAFQNFAEAVFTGPGRGLAEILRRHIPKRTYRSLADRHGIPDGGLPKDLTLTQWIALFQASQPSYAPGAPGTRMPGQGGGAGGRDYDSETSRAAVPGSRRYGPTRGGEPCAPRAQVRQTKGRQGARGSSYGRRTGR	70.54	gnl|BL_ORD_ID|1123|hsp_num:0	1224			39	321	narbomycin; methymycin; pikromycin
BGC0000265.1|Rhodomycin_5 # 3317 # 4924 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.728	BGC0000265.1|Rhodomycin_5 	3317	4924	+	Loose	550	114.39	Nocardia farcinica rox	32.7	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGAACGACCACGAGGTCGATGTTCTGGTGGTGGGTGCGGGCCTCGGGGGCCTGTCGACGGCGATGTTCCTCGCCCGGCAGGGCGTCCGCGTGCTCGTGGTGGAGCGCAGGCCGGGCCTCTCGCCCTATCCGCGGGCCGCCGGGCAGAACCCGCGGACCATGGAGCTGCTGCGCATCGGGGGCGTCGCGGACGAGGTGGTCCGGGCCGACGACATCCGCGGCACCCAGGGCGACTTCGTCATCCGGCTCGCCGAGAGCGTGCGGGGCGAGATCCTGCGGACCGTCTCGGAGAGCTTCGACGACATGGTGGCCGCCACCGAGCCGTGCACACCGGCCGGCTGGGCGATGCTGTCCCAGGACAAGCTGGAGCCGATCCTGCTCGCGCAGGCGCGCAAGCACGGTGGCGCCATCCGCTTCGGCACCCGGCTGCTGTCGTTCCGCCAGCACGACGACGACGCCGGCGCCGGCGTCACGGCCCGGCTGGCCGGGCCGGACGGCGAGTACGACCTGCGCGCCGGGTATCTCGTGGGCGCCGACGGCAACCGCAGCCTGGTGCGGGAGTCGCTGGGCATCGGGCGGTACGGGCACGGCACGCTGACCCACATGGTCGGGGTCATCTTCGACGCGGACCTCTCCGGCATCATGGAGCCGGGCACGACCGGCTGGTACTACCTCCACCACCCGGAGTTCAAGGGCACGTTCGGGCCCACGGACCGGCCCGACCGGCACACCCTCTTCGTCGAGTACGACCCCGACGAGGGCGAGCGCCCCGAGGACTTCACACCGCAGCGCTGCGTCGAACTCATCGGCCTCGCCCTGGACGCCCCCGAGGTGAAGCCCGAGCTCGTCGACATCCAGGGCTGGGAGATGGCGGCCCGCATCGCCGAACGCTGGCGCGAGGGGCGGGTGTTCCTGGCCGGGGACGCGGCGAAGGTCACCCCGCCGACCGGGGGCATGAGCGGCAACGCGGCCGTCGCCGACGGGTTCGACCTGGCCTGGAAGCTCGCGGCGGTGCTGCAGGGGCAGGCCGGGGCGGGCCTGCTCGACACCTACGAGGACGAGCGCAAGGTCGCCGCGGAGCTGGTCGTGGCCGAGGCGCTGGCGATCTACGCGCAGCGGATGGCGCCGCACATGGCGGAGGTGTGGGACAAGTCGGTGGGGTACCCCGAGACGCTGCTCGGCTTCCGCTACCGCTCCTCGGCGGTCCTGGCCACGGACGACGACCCGGCGCGGGTGGAGAATCCGCTGACGCCGAGCGGGCGTCCCGGCTTCCGGGGGCCGCATGTCCTGGTGTCGCGGCACGGGGAGCGGCTCTCCACGGTCGATCTGTTCGGTGACGGGTGGACGTTGCTGGCGGGGGAGCTGGGGGCGGACTGGGTCGCGGCGGCGGAGGCGGTCTCTGCGGAACTGGGAGTGCCTGTGCGGGCGTACCGGGTCGGGGCGGGGCTGACTGATCCCGAGAGCGCGGTGTCCGAGCGGTACGGCATCGGGAAGGCGGGGGCGAGTCTGGTGCGGCCGGACGGGATTGTGGCGTGGCGTACGGATGAGGCGGCGGCTGATGCGGCTCAGACTCTCGAAGGGGTTCTGCGTAGGGTTCTTGACCGCTGA	MNDHEVDVLVVGAGLGGLSTAMFLARQGVRVLVVERRPGLSPYPRAAGQNPRTMELLRIGGVADEVVRADDIRGTQGDFVIRLAESVRGEILRTVSESFDDMVAATEPCTPAGWAMLSQDKLEPILLAQARKHGGAIRFGTRLLSFRQHDDDAGAGVTARLAGPDGEYDLRAGYLVGADGNRSLVRESLGIGRYGHGTLTHMVGVIFDADLSGIMEPGTTGWYYLHHPEFKGTFGPTDRPDRHTLFVEYDPDEGERPEDFTPQRCVELIGLALDAPEVKPELVDIQGWEMAARIAERWREGRVFLAGDAAKVTPPTGGMSGNAAVADGFDLAWKLAAVLQGQAGAGLLDTYEDERKVAAELVVAEALAIYAQRMAPHMAEVWDKSVGYPETLLGFRYRSSAVLATDDDPARVENPLTPSGRPGFRGPHVLVSRHGERLSTVDLFGDGWTLLAGELGADWVAAAEAVSAELGVPVRAYRVGAGLTDPESAVSERYGIGKAGASLVRPDGIVAWRTDEAAADAAQTLEGVLRRVLDR	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	113.11	gnl|BL_ORD_ID|4834|hsp_num:0	5821			3	993	rifampin
BGC0000265.1|Rhodomycin_6 # 5030 # 6070 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.691	BGC0000265.1|Rhodomycin_6 	5030	6070	-	Loose	800	25.7942	Chlamydia trachomatis intrinsic murA conferring resistance to fosfomycin	29.58	3003785	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic target alteration	antibiotic-resistant murA transferase	ATGCCAGAGCACCGTCAGCAACGGGCGCTCCGCATGGGCGTGATCGGCACGGCGAACATCGCGATTCGCCGGATCATGCCCGTGCTCGCCGCGCATGACCACGTCGACCTTGTCGCGGTGGCCAGCCGGGACAAGGCCCGGGCCGAGCGGGTGGGGGCCGCTTTCGGCTGCGGTGGCGTGGGGGATTACGCGGCGCTCGTCGAGCGGGACGACCTTGACGCCGTCTATATTCCGCTGCCGCCCGGCATGCATCACGAGTGGGCGCTGCGGGCTTTGCGTTCGGGAAAGCACGTGCTGGTCGAGAAACCGATGTCGGACACGTACGAGAAAACTCTCGAGCTGATGTCGACCGCGTCGGAACTCGGACTCGTGCTCGCCGAGAACTTCATGTTCCTGCACCATTCCCAGCACGCGGCGGTACGCGCGATGCTCGACGAGTCCGTGGGAGAACTGCGGCTCTTCTCCGGGTCGTTCGCCGTGCCGCCGCTGGCACCCGAGTCGTTCCGGTACCAGCCGGCCCTGGGCGGGGGCGCGTTGCTCGACGTCGGGGTGTATCCGCTGCGGGCGGCCCAGCTGTATCTCACCGGGGAACTCGACGTCCTCGGGGCGTGTCTGCGCGTCGACGAGACGACCGGGGCCGATGTGGCGGGCAGTGTGCTGCTGAGCGACGACCGGGGAGTGACGGCCCAGCTGGACTTCGGCTTCGAGCACTCCTACCGGTCGACCTACGCGCTGTGGGGCAACCGGGGGCGGGTGAGCGTCCGGCGTGCCTTCACACCGCCGGAGCAGCTGAAGCCGGTGGTCAGGATCGAGCAGCAGGACGTGGTGACGGAGCGGTCGCTGCCCGAGGACAACCAGGTCTTCAACGCGATGGACGCCTTCGTCCGCGCGGCCCTCACGAACACCGGCCCCCTCACCGACACCTCGGCGATCCAGCGCCAGGCCCTGCTGCTCGACCGGGTCCGCCGAGCGGCCCGTCTCATAGGCGACCCGAAGTCCCGCCCGCATGACGTCCTCGCGCAGGACACAGGGCTCAGCTGA	MPEHRQQRALRMGVIGTANIAIRRIMPVLAAHDHVDLVAVASRDKARAERVGAAFGCGGVGDYAALVERDDLDAVYIPLPPGMHHEWALRALRSGKHVLVEKPMSDTYEKTLELMSTASELGLVLAENFMFLHHSQHAAVRAMLDESVGELRLFSGSFAVPPLAPESFRYQPALGGGALLDVGVYPLRAAQLYLTGELDVLGACLRVDETTGADVAGSVLLSDDRGVTAQLDFGFEHSYRSTYALWGNRGRVSVRRAFTPPEQLKPVVRIEQQDVVTERSLPEDNQVFNAMDAFVRAALTNTGPLTDTSAIQRQALLLDRVRRAARLIGDPKSRPHDVLAQDTGLS	MPGIKVFGETVLRGSVRVSGAKNATTKLLVASLLSDQRTILKNVPNIEDVRQTVDLCRVLGAIVEWDQQAQVIEIHTPRILLSKVPPQFSCVNRIPILLLGALLRRCPYGIFVPILGGDAIGPRTLHFHLEGWKKLGAEIVISDEGYWASAPNGLVGAHITLPYPSVGATENLILASVGAQGRTIIKNAALEVEIIDLIVFLQKAGVEITTDNDKTIEIFGCQDFYSVEHFIIPDKIEAASFGMAAVVSQGRIFVEQARHEHMIPFLKVLRSIGGGFSVHENGIEFFYDKPLKGGVLLETDVHPGFITDWQQPFAVLLSQSEGCSVIHETVHENRLGYLKGLVKMGAHCDLFHECLSAKSCRYSTGNHPHSAVIHGPTPLQATDLVIPDLRAGFAYVMAALIAEGGASWIENTEMLDRGYTDWRGKLERLGAKVLARDAVSVYV	77.93	gnl|BL_ORD_ID|2351|hsp_num:0	2291			714	912	fosfomycin
BGC0000265.1|Rhodomycin_7 # 6233 # 7648 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.796	BGC0000265.1|Rhodomycin_7 	6233	7648	+	Loose	1200	28.4906	TaeA	32.08	3003986	protein homolog model	n/a	n/a	pleuromutilin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGACGGCGGCGACGAATGCCCTGGGGCGCGAACTGCAACTCGTCCACGCGGCACAGTGGCTCTACGCGATCAACGCGGAGCCGTTCGTACCGGGGGAGGGTGACCCGTATGCCCGGCTGGTACGGGGGTTCGAGAGCGGCGAGAACGGCACGGACGACGCGGGGGGAACCCTCGCGTCGATCGCGGAGCGGGGGCCGGTGTGGCGCAGCCGGCTCGACACCTGGGTGGTCACCGGCCCCGCGGCGCTGCGGGAGTTGTCCGCCGGCGCGGAACCGGCGGTGTCCGCCGCGGTGCCGCAGGCGGAGGCCTGGCTGCCCGACCCGGAGCGGCAGCGCACGACGGGACTCGCCCGGGACCTGGCGCGGCGGGGCGGGACGAGGGCCGTGGGGAGGCTGGCCGGATCGCTGCGGGAGCAGGCCGGGCAGGCCGCGGCCCGGCTCGGCCCGGGTCCGGTCGACCTGGTGGCCGACTTCGCCGAGCCGCTGACCGCGGCCGGGTACGCCGCGGTCCTGGACGTCCCCGAGGAGCGGCGCGCGGCGTTCGCCGCCGACCTCGCCGCGGCGGCCCCGGCCGTGGACGCGCTGCTCTGCCCGCAGACGCTGGACACGACGCGGCGCCTGGCGGCAGGCGTACGCGGACTCCGGGAACTCTTCGCCGGGCGCGCTCACGCGGAGGCGGACCTGCTGCTCGCGGTGGCCGGGGCCCGGGCCGCGGCGGACCTGCTCGGCGACGCGCTGCGCAGGCTCCTCGACCGGCCGCGGGAGTGGGCGCTGCTGCGCTCGGACCCCGCGCACGCTGCCCGTCTGGTCGAGGAGGTACTGCACCAGCGGCCGCCGTGGCGGGCGTGCCCCCTGGTGGCCCTCGCCACGGCCGAGGTGGCCGGCACCCGTATCGAGGCCGGTGACAGCCTGACCGCCATCACGACCGCCGCCGCCGTGCCGGGTGGGCCCAGCGGCATCGCTGGGCCCACCGGGACCGCCGCGGCCGACGGGGCCAGCCGGACCGCCGGGGGCACCGTGCCCCCCGGCACCGCCGGGATCAGTCGGACCGCCGGGGCCACAGTGCCCGCCGGAGCCGCAGGAGCCGCCGGGACCGGGGCCGCCGGGGGCGTCGGCACCGCCGAGACCACCCACACCGGCCGGGTCGCCGGCACCGGCGGTGCCGGCGAACCCGGCGCGGTCACCGTGCTCGGCGAGGCCACCAGGACCAACGGCGTCCCGACGCCCCTTCCCGTGGCCGCCTGCGCCACCCTGCTCCCGGCCGCGCGGGCGCTCGCCGAGCACGCGCTGGTGGCGCTGGCCGCGCGGTTCCCGCTGCTGCGGCCGGACGGCGAGCCGGTGCGCACGCGCCGGGCGCCCCTGACCCGGCGCCTGGTCAGGCTGCCGGCCCGACTCGGCGAGGAGGAGACGCGATGA	MTAATNALGRELQLVHAAQWLYAINAEPFVPGEGDPYARLVRGFESGENGTDDAGGTLASIAERGPVWRSRLDTWVVTGPAALRELSAGAEPAVSAAVPQAEAWLPDPERQRTTGLARDLARRGGTRAVGRLAGSLREQAGQAAARLGPGPVDLVADFAEPLTAAGYAAVLDVPEERRAAFAADLAAAAPAVDALLCPQTLDTTRRLAAGVRGLRELFAGRAHAEADLLLAVAGARAAADLLGDALRRLLDRPREWALLRSDPAHAARLVEEVLHQRPPWRACPLVALATAEVAGTRIEAGDSLTAITTAAAVPGGPSGIAGPTGTAAADGASRTAGGTVPPGTAGISRTAGATVPAGAAGAAGTGAAGGVGTAETTHTGRVAGTGGAGEPGAVTVLGEATRTNGVPTPLPVAACATLLPAARALAEHALVALAARFPLLRPDGEPVRTRRAPLTRRLVRLPARLGEEETR	MNILTVEQVTKSYGDKILFQDASFGMEDQDKIGIIGVNGTGKSTFLRVIAGLEPPDSGKISMGNRIRVRYLAQNPEFDPDKTVLQQVFEGDLPEMKAVREYTETMELLELHPSHEELQQKLLKLNQTLETLQAWQLESDAKTILSKLGIRNYEAKMGTLSGGQRKRVALAAALIQPSDLLILDEPTNHIDNESVAWLEQYLQKRRGALLMITHDRYFLDRVANVMLELDHGRLFRYEANYSRFLELKAEREEREAASEQKRQNLLRSELAWIRRGAKARTTKQKARIERFEKLKDQEMVHSSGELDVSVASTRLGRKILEIEGLRMKIDDKTLIQDLSYIAVPEDRIGIVGPNGSGKSTLLNLIAGRIQPGGGEVVLGPTVKLGYFTQEHQEMDGSQRVIEYIKDEAEVVRTADGSAITAAQMLERFLFPPALQWTPIAKLSGGEKRRLYLLRVLMSAPNVLLLDEPTNDLDIQTLSVLEQYLDEFPGVCIVVSHDRFFLDRTVDKIMAFEGDGQIRVHVGSYSEYAEWMQRHGGEASGSKAEASIAKSASGSSDGTDSDSAKEAPRERLKFSYKEQREFDQIDGLIEDTESKLASIQSEMETAGSDAARLQELMKAQEETERELEHLMERWTYLNELAEKIEQSKKS	72.69	gnl|BL_ORD_ID|2230|hsp_num:0	2522			957	1116	pleuromutilin
BGC0000265.1|Rhodomycin_8 # 7645 # 8931 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.716	BGC0000265.1|Rhodomycin_8 	7645	8931	+	Loose	700	54.6842	oleD	29.17	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGAGGGTTCTGTTCACCTCACTGGCCCACCACACCCACTACTACCCGCTCGTACCGCTCGCCTGGGCGCTGCGCACCGCGGGCCACGAGGTGCGGATCGCCAGCCAGCCCGAGCTGACCGACGTCATCACGGGTACGGGACTGACGGCCGTCCCCGTGGAGTGGTCGCTCGGCGCCCTGGAGGACCTCGGGCTGCTCGGCAAGCTGCACGACGAGGCCTCGGCCCATGTGCAGGGCTTCGACTACGCAGCCCGGGGCGAACACCCCTGGAGCTACGAGCAGTTGCTGGCACTGGAGAACATCATGGTGCCCACGCTCTACGGCGCGCTCAACAACGACACCATGGTCGACGCGCTCGTGGACTTCGCCCGCTCCTGGCAGCCCGACCTCGTCGTCTGGGAGACCTTCACCCTCGCCGGGGCCATCGCGGCCCGGGTGACGGGCGCGGCGCACTGCCGGCTGGTCTCGGGCCCCGACATCAGCGTGCGGGCCCGCAAGGAGTTCCTGCGGCTGGCCGCCGAGCAGGAGCCGGAGCACCGCGAGGACCCCACCGCCGAGTGGCTGGAGCGCACGCTGCGGCGGCTGGGATCCGACGCCGGGTTCGACGAGGACATGGTCACCGGGCAGTGGACGGTCAACACCACACCGCCCAGCACCCAGCTCGACCTGAAGCTGCCGACCGTGCAGGTGCGCCACGTGCCGTACAACGGCCCCGCGGTGGTGCCGGACTGGCTGCGGGCCGACCCCGGGCGCAGCCGCGTCTGTGTGACGCTCGGCTCCTCGGCCTCCGACGTGGGCGTCGACATGGCCGAGCTCCTGGCCCACCTCGCGGAGCTGGACGCGGAGATCGTCGCGACCGTCGACGAGGCGACCCGCGAGGCCGCCGGTGACCTGCCGGACAACGTACGCCTGGTCGACTTCGTCCCGCTCAACGACCTGCTGCCCACGTGCGACGCGATCGTGCACCACGGCGGTGTCGGCACCAAGGCGACGGCCGAACTGCACGCCGTGCCCCAGCTGATCCTGGCCTTCGGCTGGGACACCGAGGTCATGGGGCGCGGACTGGAGGACATCGGCGCCGGCCTGTGCGTGCCGAGCGCCGACCTGCTGCCGGACGTCCTGCGCAAGCAGGTCCAGCGGCTGGTCGGCGACCCGTCGTTCGCACGTGGCGCCCGCAGGCTTCAGGAGGAACTGCTCGCGGTGCCCAGTCCCAACGAGGTCGTTCCGGTGCTGGAACGGCTGGTCGCCGAGCACGGCACGCACGGCTCAGTCCACGACCGAGGGTGA	MRVLFTSLAHHTHYYPLVPLAWALRTAGHEVRIASQPELTDVITGTGLTAVPVEWSLGALEDLGLLGKLHDEASAHVQGFDYAARGEHPWSYEQLLALENIMVPTLYGALNNDTMVDALVDFARSWQPDLVVWETFTLAGAIAARVTGAAHCRLVSGPDISVRARKEFLRLAAEQEPEHREDPTAEWLERTLRRLGSDAGFDEDMVTGQWTVNTTPPSTQLDLKLPTVQVRHVPYNGPAVVPDWLRADPGRSRVCVTLGSSASDVGVDMAELLAHLAELDAEIVATVDEATREAAGDLPDNVRLVDFVPLNDLLPTCDAIVHHGGVGTKATAELHAVPQLILAFGWDTEVMGRGLEDIGAGLCVPSADLLPDVLRKQVQRLVGDPSFARGARRLQEELLAVPSPNEVVPVLERLVAEHGTHGSVHDRG	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	103.13	gnl|BL_ORD_ID|1253|hsp_num:0	1367			672	1233	erythromycin; tylosin
BGC0000265.1|Rhodomycin_10 # 10252 # 11046 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.721	BGC0000265.1|Rhodomycin_10 	10252	11046	+	Loose	400	27.7202	VIM-61	30.77	3005509	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	VIM beta-lactamase	ATGTCCTCGAGGTTCACACCAACCAGCCGGGTCGCCGTCGTCACCGGCGCCACCAGCGGGATCGGCCTCTCCGTCACACGGTCCCTGGCCGCCGTCGGCCACCGCGTGTTCCTCTGCGCCCGGGACGCCGACCGGGTCGCGCTCACGGTCAAGGAGCTGCGCGCCGAGGGCCACGACGTGGACGGCGCCGCCTGCGACGTACGGGACGTGGCCCAGATCGAGTCGCTGGTGTCCGCGGCGGTGGAGCGCTACGGGCCCGTCGAGGTGCTCGTCAACAACGCCGGCCGCAGCGGCGGCGGCCCCACGCACACCATCGCCGACGAGCTGTGGGACGACGTGATGGCCACCAACCTGGACAGCGTCTTCCGCGTCACCCGTGCCGTCCTGACCACCGGCCGCATGCGGGAGGGCGGCTGGGGCCGGGTCGTGAACATCGCCTCCACCGGCGGCAAGCAGGGCGTGGTGCTGGGCGCCCCCTACTCCGCCTCCAAGCACGGGGTCGTCGGCTTCACCAAGGCCCTGGGGCTGGAACTGGCCAAGACCGGGATCACGGTCAACGCGGTGTGCCCCGGCTATGTGGAGACGCCCATGGCGGTGCGGGTCCGGCAGGGCTACGCCGCCGCCTGGGAGACCTCCGAGGAGGAGGTGCTCGACCGGTTCCAGGCCAAGATCCCGCTCGGCCGCTACACCACGCCCGACGAGGTGGCGGGCATGGTCGGCTACCTGCTGACCGACGCGGCATCGTCCGTCACCGCGCAGGCGATCAACGTCTGCGGCGGGCTGGGAAACTACTGA	MSSRFTPTSRVAVVTGATSGIGLSVTRSLAAVGHRVFLCARDADRVALTVKELRAEGHDVDGAACDVRDVAQIESLVSAAVERYGPVEVLVNNAGRSGGGPTHTIADELWDDVMATNLDSVFRVTRAVLTTGRMREGGWGRVVNIASTGGKQGVVLGAPYSASKHGVVGFTKALGLELAKTGITVNAVCPGYVETPMAVRVRQGYAAAWETSEEEVLDRFQAKIPLGRYTTPDEVAGMVGYLLTDAASSVTAQAINVCGGLGNY	MFQIRSFLVGISAFVMAVLGSAAYSAQPGGEYPTVDDIPVGEVRLYKIGDGVWSHIATQKLGDTVYSSNGLIVRDADELLLIDTAWGAKNTVALLAEIEKQIGLPVTRSISTHFHDDRVGGVDVLRAAGVATYTSPLTRQLAEAAGNEVPAHSLKALSSSGDVVRFGPVEVFYPGAAHSGDNLVVYVPAVRVLFGGCAVHEASRESAGYVADANLAEWPATIKRIQQRYPEAEVVIPGHGLPGGLELLQHTTNVVKTHKVRPVAE	99.62	gnl|BL_ORD_ID|4639|hsp_num:0	5710			273	540	
BGC0000265.1|Rhodomycin_11 # 11055 # 12413 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=3-4bp;gc_cont=0.726	BGC0000265.1|Rhodomycin_11 	11055	12413	+	Loose	950	28.8758	msrC	29.36	3002819	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target protection	msr-type ABC-F protein	ATGTCGGACGAGACCGTGCACACCACCGTCCACGAGATCGAGGTACGGGCCCCGGCCGAGGCGGTGTTCGACCTGGTCGCCGGGGCCTCCCGCTGGCCGGTGCACTTCCCGCCGAGCGTGCACGTCGAGCGCCTGGAGGGCGACGACCGGCAGGAGCGGCTGAGGATCTGGGCGACGGCCAACGACGAGGTCAAGAGCTGGACCTCGCGCCGCGAACTGGACCGGGCCGGATTACGGGTGACGTTCCGGCAGGAGGAGTCGCGGGCGCCGGTGCGGAGCATGAGCGGCGAGTGGCTGCTGGAGCCGCTCGGCGACAAGGGGACCCGGGTGCGGTTCACCCACGCGTTCACCGCCGTGGACGACGCCCCCGAGAACGTCGAGTGGATCCGCCGGGCCATCGACACCAACACCGGGTCCGAACTCGAGGCCCTGCGCCGGGGCGTGGAGGACGCGGACCCGGAGCTCACGTTCACGTTCGACGACAGTGTGCGCGTCGAGGGCTCGGCGAAGGACGCGTACGAGTTCATCCGCGCGGCCGACCGCTGGACGGAGCGGCTGCCGCACGTCGCCCGGGTCGTCCTCACCGAGGACACCCCGAACGAGCAGATCCTGGAGATGGACACGCTCACCGCCGACGGCGCGACCCACACCACCCGTTCGGTGCGCGTCTGCTTCCCCGCCGAGCGGATCGTCTACAAGCAGATCCGGACACCCGCGCTGATGGCCGCCCACACCGGCGAATGGATCTTCGAGGAGGACGACAAGGGCTGCACCGTCACCTCCCGGCACACCGTGCGGATCGAGCCGAACGCCGTGACGAGCGTCCTCGGTCCGGCGGCGGACGTGGCCGCCGCCCGCACCATGATCCGGGAGGCGCTCGGCCGCAACAGCCTCACGACGCTGCGGTGCGCGGCCGACCACGCCGAGCGGCTGCGCGGCGCCGAGCCGGTCCCCGCCGGGACGTACGTCGCCGTGCAGCAGTTCTACGCCCGGCAGATGCGGCTCCTCGACGAGCGGCGGGCCGAGGAGTGGGCCCGGACGTTCACCGAGGACGGCGTCTTCGCGCAGAACATCGCCCCCGAGCCCCTGCGCGGCCGGGACGCCGTGGCCGCGGCCGTACGCCGCAACCTGGAGCGGACGGCGGACACACCGGAGCAGCGGCGGGATGTGTTCTCCATGCTCACCGTGGTGCCCGGGCCGGACGGTTCCCTGAGCACCCGCTGCTACGCACAGGTCCTGGTCACCCCGGCCGGGGGACCGGCCAGGCTGCACCTGAGCGCGGTGTGCGAGGACGAACTGGTGCCGCACGGCGACGGCTGGCTGGTGCGCCACCGCAGGGTCGAGCACGACGGAGTCTGA	MSDETVHTTVHEIEVRAPAEAVFDLVAGASRWPVHFPPSVHVERLEGDDRQERLRIWATANDEVKSWTSRRELDRAGLRVTFRQEESRAPVRSMSGEWLLEPLGDKGTRVRFTHAFTAVDDAPENVEWIRRAIDTNTGSELEALRRGVEDADPELTFTFDDSVRVEGSAKDAYEFIRAADRWTERLPHVARVVLTEDTPNEQILEMDTLTADGATHTTRSVRVCFPAERIVYKQIRTPALMAAHTGEWIFEEDDKGCTVTSRHTVRIEPNAVTSVLGPAADVAAARTMIREALGRNSLTTLRCAADHAERLRGAEPVPAGTYVAVQQFYARQMRLLDERRAEEWARTFTEDGVFAQNIAPEPLRGRDAVAAAVRRNLERTADTPEQRRDVFSMLTVVPGPDGSLSTRCYAQVLVTPAGGPARLHLSAVCEDELVPHGDGWLVRHRRVEHDGV	MENLAVNITNLQVRFGNQLELSIDSLRVYQQDRIGIIGENGVGKTTLLKLIVGELIPNQGKIQTEITFNYLPQLTYLAEAKDLNLELASHFQLKLEETSERKWSGGEERKIELIRLLSSYEQGMLLDEPTTHLDRKSMDRLIEELRYYYGTLIFVSHDRYFLDELATKVWEVKDGEIREFPENYSAYLTQRELEKKTQLREAESIMKEKKRLEKSIQEKKKQAEKLEKVSSKKKKQQIRPDRLSSSKQKDSVQKAIQKNTKTLERRLQKIGETTKPQQMKQIRFPVPKSLELHNRYPIMGQNIQLERSGRTLLINSDFQFSLGKKIAIVGENGSGKTTLLEHIRKQGEGILLSPKVSFQVYQQKDYQMTSEESVIRFVMRQTEFSESLVRSLLNHLGFAQETLTKPLCTLSGGEATRLTIALLFTKPSNVLLLDEPTNFIDVATIEALEQLMQVYPGTILFTSHDSYFVERTADEVYEIKGQKIKKVLTRNF	91.87	gnl|BL_ORD_ID|1891|hsp_num:0	2054			1122	1437	erythromycin; quinupristin
BGC0000265.1|Rhodomycin_12 # 12889 # 12969 # -1 # ID=1_12;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.704	BGC0000265.1|Rhodomycin_12 	12889	12969	-	Loose	700	21.1718	DHA-18	37.5	3002149	protein homolog model	n/a	n/a	cephalosporin; cephamycin	antibiotic inactivation	DHA beta-lactamase	ATCACCGCGCTGGCCGACCCCGAAGGCCGCTACATGACGGGCGCGGTCGTCCCGGTCGACGGCGGTCTCTCCCTGACCTGA	ITALADPEGRYMTGAVVPVDGGLSLT	MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKETALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSWKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESVQSRYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE	6.86	gnl|BL_ORD_ID|1357|hsp_num:0	1472			303	375	
